Whether the association of genetic variants that inactivate ANGPTL4 with reduced type 2 diabetes risk is mediated exclusively via modulation of lipoprotein lipase activity or involves other mechanisms remains to be clarified. This evidence concerns the gene LPL and type 2 diabetes mellitus.